Capacity to supply Moderna's COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, following an agreement to set up a new production line at contract manufacturer
China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion.